We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Hong Kong Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Hong Kong Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • August 2014
  • 114 pages

BMI View: Hong Kong was in the past an attractive commercial prospect, largely propped by the widespread use of patented medicines. However, the climate of cost-containment over the past decade represents and the rising prominence of the pharmaceutical industry of mainland China have somewhat diminished ...

Industries: Drug and Medication | Countries: China, United States, Asia

Hawaii Biotech, Inc. - Product Pipeline Review - 2014

Hawaii Biotech, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • by Global Markets Direct
  • August 2014
  • 31 pages

Hawaii Biotech, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Hawaii Biotech, Inc. - Product Pipeline Review - 2014', provides an overview of the Hawaii Biotech, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current ...

Industries: Drug and Medication | Countries: United States

Physician Views: What impact has the controversy surrounding use of testosterone products had on urologists?

Physician Views: What impact has the controversy surrounding use of testosterone products had on urologists?

  • $ 645
  • Industry report
  • by Firstword Pharma
  • August 2014

The number of prescription written for testosterone replacement therapy has skyrocketed over the past couple decades thanks in no small measure to a concerted effort on the part of a handful of drugmakers to heighten awareness of hypogonadism - or "Low T" as it is often referred to - through direct-to-consume ...

Industries: Drug and Medication | Countries: United States

Jiangsu Hengrui Medicine Co., Ltd. (Symbol:600276) SWOT Analysis, Strategy, Revenues and Profits

Jiangsu Hengrui Medicine Co., Ltd. (Symbol:600276) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • by Global Data
  • August 2014
  • 34 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Jiangsu Hengrui Medicine Co., Ltd. SWOT Analysis report provides you ...

Industries: Drug and Medication | Countries: China, United States

American Bio Medica Corporation (Symbol:ABMC) SWOT Analysis, Strategy, Revenues and Profits

American Bio Medica Corporation (Symbol:ABMC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. American Bio Medica Corporation SWOT Analysis report provides you ...

Industries: Drug and Medication | Countries: United States

Psychemedics Corporation (Symbol:PMD) SWOT Analysis, Strategy, Revenues and Profits

Psychemedics Corporation (Symbol:PMD) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Psychemedics Corporation SWOT Analysis report provides you a strategic ...

Industries: Drug and Medication | Countries: United States

Mylan Laboratories Limited - Strategic SWOT Analysis Review

Mylan Laboratories Limited - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 15 pages

Summary Mylan Laboratories Limited (Mylan Laboratories) is a pharmaceutical company. The company's product segments include manufacturing and supply of active pharmaceutical ingredients (APIs). The company offers its products in various therapeutic categories, including central nervous system (CNS) agents, ...

Industries: Drug and Medication | Countries: United States, India, World, Australia, South Africa, China

InforMedix Holdings, Inc. (IFMX) - Strategic SWOT Analysis Review

InforMedix Holdings, Inc. (IFMX) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 15 pages

Summary InforMedix Holdings, Inc. is engaged in the development, patenting and integrating of Med-eXpert system, an integrated Internet-based communication system that offers data analytics; and a database software platform to examine patient medication adherence and health status. Currently, the company ...

Industries: Drug and Medication | Countries: United States

Lavipharm S.A. (LAVI) - Financial and Strategic SWOT Analysis Review

Lavipharm S.A. (LAVI) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 25 pages

Summary Lavipharm S.A (Lavipharm) is a an integrated company, which carries out developing, manufacturing, marketing and distribution of pharmaceutical, cosmetic, consumer health and over the counter (OTC) products. It provides various products for chronic pain, respiratory system, anti-inflammatory, ...

Industries: Drug and Medication | Countries: Greece, France, United States, Cyprus

Ginger Oil AB (GIOI) - Financial and Strategic SWOT Analysis Review

Ginger Oil AB (GIOI) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 25 pages

Summary Ginger Oil AB (Ginger Oil) is an oil and natural gas exploration and development company, based in Sweden. It operates through the exploration, exploitation, development, extraction and production of oil and natural gas. Ginger Oil involved in exploration of new deposits and the expansion of ...

Industries: Drug and Medication | Countries: United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.